Role of LDLR in regulating metabolism of Apolipoprotein E and Amyloid-beta
LDLR 在调节载脂蛋白 E 和淀粉样蛋白-β 代谢中的作用
基本信息
- 批准号:9345995
- 负责人:
- 金额:$ 39.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-15 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:Abeta clearanceAddressAffectAlzheimer&aposs DiseaseAmyloid beta-ProteinAmyloid beta-Protein PrecursorAnimalsApolipoprotein EBiologyBrainCREB1 geneCellsClinicalCognitionCollaborationsComputer SimulationDataDepositionDimerizationGenotypeHourIn VitroKnock-outKnockout MiceLDL-Receptor Related Protein 1LDLR geneLengthLipidsLipoprotein ReceptorLow Density Lipoprotein ReceptorMass Spectrum AnalysisMediatingMemoryMemory LossMetabolismMethodsMicrodialysisMicrogliaMolecularMusN-MethylaspartateNeuronsPathogenesisPathologicPathway interactionsPharmacologyPhenotypePhosphorylationPhysiologic pulseProtein IsoformsProteinsReceptor GeneReportingRoleSenile PlaquesSignal TransductionSourceStructureStructure-Activity RelationshipSynapsesSynaptic plasticityTestingTissuesTranslatingTranslational Researchamyloid formationamyloid precursor protein processingapolipoprotein E receptor 2basecell typecytokinedimerexperimental studygenetic risk factorgenetically modified cellsin vivoinnovationinsightmolecular dynamicsmouse modelneuroinflammationnoveloverexpressionprotein Eprotein aggregationreelin receptorsimulationstable isotopesynaptic functiontau Proteinstau phosphorylationtraffickingtranslational medicinetreatment strategyubiquitin-protein ligase
项目摘要
PROJECT SUMMARY/ABSTRACT
Apolipoprotein E (ApoE) genotype is the strongest genetic risk factor for Alzheimer’s disease (AD). Prevailing
evidence suggests that ApoE isoforms affect amyloid β (Aβ), tau, neuroinflammation, and synaptic plasticity. In
addition to isoforms, alteration in ApoE protein levels has been shown to influence neuroinflammation and Aβ
clearance. Previously, we reported the critical roles of ApoE receptor, low density lipoprotein receptor (LDLR),
in regulating ApoE clearance and Aβ levels in the brain. Overexpression of LDLR in the brain dramatically
inhibits amyloid formation by decreasing ApoE level and increasing Aβ clearance. These beneficial effects
were seen with as little as just 2-fold over-expression of LDLR. However, translating these observations into
therapy has been hampered by a poor understanding of cellular and molecular mechanism and a paucity of
effective approach to regulate the levels of LDLR in the brain. To overcome this critical barrier, we propose to
investigate cellular mechanism by which Inducible Degrader Of LDLR (IDOL) regulates LDLR, ApoE, Aβ, and
tau. In collaboration with Dr. Tontonoz (HHMI, UCLA), we found that global deletion of IDOL gene dramatically
increases LDLR levels and decreases apoE levels in the brain. IDOL is an E3 ubiquitin ligase that ubiquitinates
LDLR and targets it for degradation. Importantly, loss of IDOL expression significantly reduced amyloid plaque
burden and ameliorated neuroinflammation in an AD mouse model. Based on these strong preliminary data,
we now propose to determine the cellular and molecular mechanism by which IDOL affects ApoE and Aβ using
primary cells isolated from global and conditional knockout IDOL mouse model. We hypothesize that the
beneficial effect of IDOL deletion is mediated through LDLR-mediated ApoE level reduction and ApoER2-
mediated Reelin signaling. To test hour hypothesis, we will apply innovative methods, such as molecular
dynamics simulation, in vivo stable isotope pulse chase mass spectrometry, and in vivo Aβ and cytokines
microdialysis. Deciphering IDOL pathway in cellular details may help better understanding ApoE signaling in
basic biology and AD.
项目摘要/摘要
载脂蛋白E(APOE)基因型是阿尔茨海默氏病(AD)的强大遗传危险因素。盛行
有证据表明,APOE同工型会影响淀粉样β(Aβ),TAU,神经炎症和突触可塑性。在
除同工型外,APOE蛋白水平的改变已被证明会影响神经炎症和Aβ
清除。以前,我们报道了APOE受体,低密度脂蛋白受体(LDLR)的关键作用,
在调节大脑中的APOE清除和Aβ水平时。大脑中LDLR的过表达急剧
通过降低APOE水平并增加Aβ清除率,抑制淀粉样蛋白形成。这些有益的效果
他们看到的只是LDLR的2倍过表达。但是,将这些观察结果转化为
对细胞和分子机制的了解不足以及缺乏
调节大脑中LDLR水平的有效方法。为了克服这一关键障碍,我们建议
研究了细胞机制,通过这些机制,LDLR(偶像)的诱导降解器调节LDLR,APOE,Aβ和
tau。与Tontonoz博士(HHMI,UCLA)合作,我们发现偶像基因的全球删除极大地删除
提高LDLR水平并降低大脑中的APOE水平。偶像是泛素化的E3泛素连接酶
LDLR并将其靶向降解。重要的是,偶像表达的丧失显着减少了淀粉样斑块
AD小鼠模型中的负担和改善神经炎症。基于这些强大的初步数据
现在,我们建议确定偶像使用偶像影响ApoE和Aβ的细胞和分子机制
从全球和条件基因敲除偶像小鼠模型中分离出来的主细胞。我们假设
偶像缺失的有益作用是通过LDLR介导的APOE水平降低和apoer2-介导的
介导的reelin信号传导。为了测试小时假设,我们将采用创新方法,例如分子
动力学模拟,体内稳定的同位素脉冲追逐质谱法,体内Aβ和细胞因子
微透析。细胞细节中的解密偶像途径可能有助于更好地理解APOE信号传导
基本生物学和广告。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jungsu Kim其他文献
Jungsu Kim的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jungsu Kim', 18)}}的其他基金
Molecular genetic analyses of transcriptional dysregulation in Alzheimers disease
阿尔茨海默病转录失调的分子遗传学分析
- 批准号:
10467106 - 财政年份:2022
- 资助金额:
$ 39.13万 - 项目类别:
Molecular genetic analyses of transcriptional dysregulation in Alzheimers disease
阿尔茨海默病转录失调的分子遗传学分析
- 批准号:
10662322 - 财政年份:2022
- 资助金额:
$ 39.13万 - 项目类别:
microRNA-758-3p in cognition and Alzheimer's Disease
microRNA-758-3p 在认知和阿尔茨海默氏病中的作用
- 批准号:
9885783 - 财政年份:2019
- 资助金额:
$ 39.13万 - 项目类别:
Role of microRNA-33 in Alzheimer's disease
microRNA-33 在阿尔茨海默病中的作用
- 批准号:
9338097 - 财政年份:2016
- 资助金额:
$ 39.13万 - 项目类别:
The role of aging-associated microRNAs in Alzheimer's disease
衰老相关的 microRNA 在阿尔茨海默病中的作用
- 批准号:
9895037 - 财政年份:2016
- 资助金额:
$ 39.13万 - 项目类别:
Role of LDLR in regulating metabolism of Apolipoprotein E and Amyloid-beta
LDLR 在调节载脂蛋白 E 和淀粉样蛋白-β 代谢中的作用
- 批准号:
9478870 - 财政年份:2016
- 资助金额:
$ 39.13万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Glymphatic impairment as a crucial factor in particulate matter exposure related development of Alzheimer's disease pathology
类淋巴系统损伤是与颗粒物暴露相关的阿尔茨海默病病理学发展的关键因素
- 批准号:
10718104 - 财政年份:2023
- 资助金额:
$ 39.13万 - 项目类别:
Neurovascular circadian oscillation in health and Alzheimer's disease
健康和阿尔茨海默病中的神经血管昼夜节律振荡
- 批准号:
10655154 - 财政年份:2023
- 资助金额:
$ 39.13万 - 项目类别:
The effects of skull malformations and intracranial hypertension on the glymphatic and meningeal lymphatic systems in craniosynostosis
颅缝早闭时颅骨畸形和颅内高压对类淋巴系统和脑膜淋巴系统的影响
- 批准号:
10574732 - 财政年份:2023
- 资助金额:
$ 39.13万 - 项目类别:
Cardiovascular Genotype and APOE ε4 Carrier Status Interaction Effects on Amyloid Load in Pre-Clinical Alzheimer's Disease
心血管基因型和 APOE ε4 携带者状态对临床前阿尔茨海默氏病淀粉样蛋白负荷的相互作用影响
- 批准号:
10664432 - 财政年份:2023
- 资助金额:
$ 39.13万 - 项目类别:
Amyloid Beta CAR Macrophages: a cell engineering strategy to clear pathogenic proteins
淀粉样蛋白 Beta CAR 巨噬细胞:清除致病蛋白的细胞工程策略
- 批准号:
10562093 - 财政年份:2023
- 资助金额:
$ 39.13万 - 项目类别: